ASP AUTOMATIC ENDOSCOPE REPROCESSOR WITH PRINTER 20301

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a *,05 report with the FDA on 2009-12-23 for ASP AUTOMATIC ENDOSCOPE REPROCESSOR WITH PRINTER 20301 manufactured by Minntech Corp..

Event Text Entries

[1315114] The customer alleged the unit was leaking. The customer stated there was a leak coming from the center apparatus inside the unit. It was discovered that the relief valve on the air compressor was leaking, indicating the air valve may have malfunctioned. The customer did not have a service box available. Subsequently, the customer stated the unit leaked a combination of cidex opa solution and water onto the floor. The customer and another healthcare worker experienced burning eyes and a headache; the symptoms cleared after approximately 30 minutes. No medical attention was sought. No over-the-counter eye drops were used. The customer left the room. The customer stated the unit is in operation. The unit is not leaking. The customer had scheduled the unit to be repaired by a certified repair person outside of asp. A service was not dispatched.
Patient Sequence No: 1, Text Type: D, B5


[8343957] (b) (4). Capital equipment evaluated at the customer site. The customer had scheduled the unit to be repaired by a certified repair person outside of asp. All related mdrs: 2150060-2009-00181, 2150060-2009-00182.
Patient Sequence No: 1, Text Type: N, H10


[8874511] Asp investigation summary: the investigation included for the aer: device history record review, service history review, complaint trending by problem codes, failure mode and effects analysis, and health hazard evaluation, and for cidex opa: failure mode and effects analysis, system hazard use and misuse analysis and a corrective and preventative action plan. The dhr (device history record) for this aer unit was reviewed and it revealed the unit met the manufacturer's specifications at the time of release. Within the past six months ((b)(6) 2009), this aer unit per account history has not observed a significant trend of this same issue. A review of the complaint history for aer units with problem code "fluid leak" did not reveal a significant trend over the past 12 months ((b)(4) 2010). A review of the complaint history for aer units with problem code "hr-headache" revealed that (b)(4) complaints were reported over the past 12 months ((b)(4) 2009 - (b)(4) 2010), which is an average of less than (b)(4) complaints per month; and therefore, does not indicate a significant trend. A review of the complaint history for aer units with problem code "hr-eye burning" revealed that three complaints were reported over the past 12 months ((b)(4) 2009 - (b)(4) 2010), which is an average of less than (b)(4) complaint per month; and therefore, does not indicate a significant trend. An assessment of the aer fmea revealed the rpns (risk priority number) for all leak related failure modes are below the threshold of 100 indicating that the associated risks are minimal. The hhe (health hazard evaluation) was reviewed for similar disinfectant leak of the aer and the hazard/risk index was 4 which indicated the associated risk is low. An assessment of the cidex opa solution fmea (failure mode and effects analysis) revealed the rpn (risk priority number) for spills/leaks is below the threshold of 100 which indicated the associated risk is minimal. The cidex opa solution/disopa shuma (system hazard use and misuse analysis) was reviewed and it was determined that the risks of user exposure due to spills all fall into category i. A capa (corrective and preventative action plan) was opened to investigate hcw (healthcare worker) reports of human reaction symptoms while working with cidex opa solution. Through the investigation, it was determined that inadequate ventilation and/or possibly user related issues were contributing to the majority of these reported human reaction symptoms. Cidex opa solution was a concomitant product. The asp tsr (technical service representative) troubleshot with the customer and found that the relief valve on the air compressor was leaking which suggested that the air valve might be malfunctioning/stuck open. The customer did not have a service box available, so the asp tsr instructed the customer to change the air valve (v3) with the waste valve (v6) and monitor the level of disinfectant in the reservoir both before and after an empty cycle. The asp tsr also provided the customer with the part number for the skinner valve. Upon follow-up, the customer stated that a few drops of water were leaking from the air compressor valve during the disinfect cycle when the unit was draining. The asp tsr gave the customer the part number for the air compressor assembly. The root cause was determined to be inadequate ventilation and inadequate ppe (personal protective equipment). The hcw was not wearing ppe. The cidex opa solution instructions for use (ifu) states that exposure to ortho-phthalaldehyde vapors should be avoided as they may be irritating to the eyes and may cause headache. In case of adverse reactions from inhalation of vapor, it is recommended that the individual move to fresh air. The ifu (instructions for use) and msds (material safety data sheet) also state that cidex opa solution should be used in a well-ventilated area and in closed containers with tight-fitting lids. If adequate ventilation is not provided by the existing air conditioning system, use in local exhaust hoods, or in ductless fume hoods/portable ventilation devices which contain filter media which absorb ortho-phthalaldehyde from the air. The ifu also states that eye protection should be worn. The msds states that cidex opa solution may cause irritation and redness to the eyes. A letter was sent to the customer recommending review of the enclosed copies of the ifu and msds. The customer did not respond to asp's attempts to obtain more information; thus, resolution of the issue could not be confirmed. Conclusion: changed from "67" to "80".
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number2150060-2009-00182
MDR Report Key1575979
Report Source*,05
Date Received2009-12-23
Date of Report2009-12-01
Date of Event2009-12-01
Date Mfgr Received2011-01-10
Date Added to Maude2011-01-27
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location0
Manufacturer ContactGINNY STEMBERGER
Manufacturer Street33 TECHNOLOGY DRIVE
Manufacturer CityIRVINE CA 92618
Manufacturer CountryUS
Manufacturer Postal92618
Manufacturer Phone9497893837
Manufacturer G1MINNTECH CORP.
Manufacturer Street14605 28TH AVE NORTH
Manufacturer CityMINNEAPOLIS MN 55447
Manufacturer CountryUS
Manufacturer Postal Code55447
Single Use3
Previous Use Code3
Removal Correction NumberNA
Event Type3
Type of Report3

Device Details

Brand NameASP AUTOMATIC ENDOSCOPE REPROCESSOR WITH PRINTER
Generic NameAER EQUIPMENT
Product CodeNVE
Date Received2009-12-23
Model NumberNA
Catalog Number20301
Lot NumberNA
ID NumberPART #: NA
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrN
Device Sequence No1
Device Event Key0
ManufacturerMINNTECH CORP.
Manufacturer AddressMINNEAPOLIS MN 55447 US 55447


Patients

Patient NumberTreatmentOutcomeDate
10 2009-12-23

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.